Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Hyaluronidase Assisted Subcutaneous Infusion in Healthy Volunteers
NCT06604546Phase 3Completed
- Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Start
- Mar 2024
- Primary completion
- May 2024
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hyaluronidase in dehydration (3 arms), sponsored by Shanghai Bao Pharmaceuticals Co., Ltd. Primary endpoint: Subcutaneous infusion rate at 4 hours. Started Mar 2024; status: completed.
02
Drugs
hyaluronidase
03
Conditions
dehydration
Beyond the preview
Go deeper on NCT06604546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06604546.